Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Bought by E Fund Management Co. Ltd.

E Fund Management Co. Ltd. lifted its stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA) by 40.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 23,361 shares of the company’s stock after purchasing an additional 6,673 shares during the quarter. E Fund Management Co. Ltd.’s holdings in Sana Biotechnology were worth $95,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. TD Asset Management Inc grew its position in Sana Biotechnology by 100.0% during the third quarter. TD Asset Management Inc now owns 362,652 shares of the company’s stock worth $1,403,000 after buying an additional 181,326 shares during the period. State of Michigan Retirement System purchased a new position in Sana Biotechnology in the 3rd quarter valued at approximately $2,663,000. Principal Financial Group Inc. raised its holdings in Sana Biotechnology by 13.1% during the third quarter. Principal Financial Group Inc. now owns 42,664 shares of the company’s stock worth $165,000 after purchasing an additional 4,928 shares during the last quarter. Jump Financial LLC purchased a new stake in Sana Biotechnology during the third quarter worth $52,000. Finally, Barclays PLC grew its holdings in Sana Biotechnology by 3.1% in the third quarter. Barclays PLC now owns 205,567 shares of the company’s stock valued at $797,000 after purchasing an additional 6,096 shares during the last quarter. Hedge funds and other institutional investors own 88.23% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on SANA shares. JMP Securities boosted their price objective on shares of Sana Biotechnology from $8.00 to $15.00 and gave the stock a “market outperform” rating in a research report on Friday, March 1st. HC Wainwright reaffirmed a “buy” rating and issued a $12.00 target price on shares of Sana Biotechnology in a research note on Thursday.

Sana Biotechnology Trading Up 1.9 %

Shares of SANA traded up $0.14 during mid-day trading on Friday, reaching $7.64. The company had a trading volume of 312,191 shares, compared to its average volume of 2,905,771. The stock has a market cap of $1.68 billion, a price-to-earnings ratio of -5.10 and a beta of 1.62. The firm has a fifty day simple moving average of $9.16 and a 200-day simple moving average of $6.49. Sana Biotechnology, Inc. has a fifty-two week low of $2.74 and a fifty-two week high of $12.00.

Sana Biotechnology (NASDAQ:SANA) last posted its earnings results on Thursday, February 29th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.38) by $0.03. During the same period last year, the business posted ($0.40) earnings per share. As a group, equities analysts predict that Sana Biotechnology, Inc. will post -1.06 EPS for the current fiscal year.

Sana Biotechnology Profile

Sana Biotechnology, Inc, a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others.